300 Longwood Avenue Boston, MA 02115 (617) 355-6000 Clinical Services (ITP/Platelet Disorders): Innovations and Research The ITP Program at Children's Hospital Boston is a world leader in ITP research. Recent studies conducted here include a trial of rituximab, a medication that demonstrated promising results in 30 percent of pediatric patients with chronic ITP. The program also hosts a registry of patients with chronic ITP, and is about to open a study to identify genetic markers that may predict disease severity and response to drug therapy. Another study is exploring the impact of this illness on quality of life. The information on this website should not be taken as medical advice, which can only be given to you by your personal health care professional. Copyright © Children's Hospital Boston. All rights reserved.